entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 20:06:40 - browse：4

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Lawsuit challenges CMS nursing home minimum staffing rule

WSS

Hospitals need to get ahead of regulations on climate change

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

As a primary care physician, here's how I hope to partner with AI

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Guardant Health colon cancer test endorsed by FDA advisory panel

Medical students need to learn the potent medicine of empathy

hotspot

entertainment

hotspot

Apple is now the first public company to be valued at $3 trillion

Louisiana bill approved classifying abortion pills as controlled substances

How to save PrEP access — and even expand it

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Continuity nursing helped my family in our darkest PICU moments

Decentralized clinical trials need collaboration to achieve wider use

Cancer drug shortages should be causing more outrage

Eyeing GLP

Apple is now the first public company to be valued at $3 trillion

Decentralized clinical trials need collaboration to achieve wider use

hotspot

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Louisiana bill approved classifying abortion pills as controlled substances

The world needs the new pandemic treaty

The Bio Revolution is changing business and society

Why we need mandatory labeling of GMO products

Making the case for fair compensation in clinical trials

explore

leisure time

focus

leisure time